HT
BHVN

HAP Trading’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

HAP Trading’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-91,752
Closed -$4.2M – 1663
2019
Q4 		$5M Buy
91,752
+73,953
+415% +$3.66M 0.27% 64
2019
Q3 		$743K Buy
+17,799
New +$752K 0.06% 250
2018
Q2 		– Sell
-20,147
Closed -$519K – 1257
2018
Q1 		$519K Buy
+20,147
New +$602K 0.03% 318

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HAP Trading's BHVN Position: Q1 2020 in Review

HAP Trading sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2020, closing a stake of 91,752 shares — an estimated $4.2M sold.

HAP Trading first reported a position in BHVN in Q1 2018 and held it in 3 quarters. The position peaked at $5M in Q4 2019. 175 funds tracked by Wall St. Rank hold BHVN as of Q1 2020.

  • HAP Trading reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2020 after selling out during the quarter.
  • HAP Trading sold 91,752 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2020, an estimated $4.2M.
  • HAP Trading first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 3 quarters.
  • HAP Trading's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $5M in Q4 2019.
  • 175 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2020.

Based on HAP Trading's 13F filing for Q1 2020, filed 8 May 2020.